Article

New marker may be more specific for prostate cancer

Researchers at Johns Hopkins have made significant progress on the development of a new serum biomarker known as Early Prostate Cancer Antigen-2.

Related Videos
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
Shot of a doctor showing a patient some information on a digital tablet | Image Credit | © bongkarn - stock.adobe.com
Stacy Loeb, MD, MSc, PhD (Hon), answers a question during a Zoom video interview
© 2025 MJH Life Sciences

All rights reserved.